Well-differentiated Liposarcoma
📧 Sign up to get email alerts when something new happens for Well-differentiated Liposarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma [Phase 1, Phase 2]
This update reports on a Phase 1/2 clinical trial evaluating the MEK inhibitor mirdametinib in combination with palbociclib for liposarcoma,…
-
CLINICAL_TRIALS trial_result · 2025-10-14Clinical Trial Update: Palbociclib and INCMGA00012 in People With Advanced Liposarcoma [Phase 2]
Phase 2 clinical trial evaluating the combination of palbociclib and INCMGA00012 in advanced well-differentiated or dedifferentiated liposar…
-
CLINICAL_TRIALS trial_result · 2017-10-25Clinical Trial Update: A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of ribociclib in patients with advanced liposarcoma, including well-differentiated…